- Home
- / Acumen Pharma
Acumen Pharma
Stock Price
$2.9
2024-10-29
Market Capitalization
$174.5 M
2024-10-29
Acumen Pharma Summary
Company Summary
- Overview
- Acumen Pharmaceuticals is a biopharmaceutical company that develops therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. It focuses on advancing a targeted immunotherapy drug candidate ACU193, that targets amyloid-beta oligomers.
- Type
- Public
- Status
- Active
- Founded
- 1996
- HQ
- Charlottesville, VA, US | view all locations
- Website
- http://www.acumenpharm.com/
- Cybersecurity rating
Table of Contents
Key People
Eric Siemers, Chief Medical Officer
Russell Barton, Chief Operating Officer
Matthew Zuga, Chief Financial Officer / Chief Business Officer
LocationsView all
2 locations detected
Charlottesville, VA HQ
United States
427 Park St
Carmel, IN
United States
11711 N Meridian St #310
Acumen Pharma Financials
Summary Financials
- Net income (Q1, 2026)
- ($20.7M)
- Cash (Q1, 2026)
- $51.8M
- EBIT (Q1, 2026)
- ($21.1M)
- Enterprise value
- $153.8M